Michaelson Jennifer sold 4,000 shares of Cullinan Therapeutics, Inc. at $12.36 for −$49.4k on Nov 5, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Chief Scientific Officer
Chief Scientific Officer
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$49,440Shares × reported price
Shares traded
4,000Common Stock
Price per share
$12.36Reported price. Read footnotes for ranges.
% of reported position traded
2.46%This security and ownership context
Holdings after
158,649Direct
Trade date
Nov 5, 2026Sell
Filed
Nov 6, 2026, 5:00 PM ET1-day reporting delay
Accession
0001193125-26-452004Code S · Transaction 395115
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 162,649 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise3,805$4.30$16,361.50Trade 395114
Nov 5, 2026Option exercise3,805$0.00$0Trade 395116
3 transaction rows in this filing. Joint filers share the same rows.

CGEM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CGEM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.5%1w ago 0%1d ago 0%
Returns since7d −31%30d90d180d1y

Footnotes in full

F1: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025. F2: 25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.